See more : Geopulse Exploration, Inc. (GPLS) Income Statement Analysis – Financial Results
Complete financial analysis of biote Corp. (BTMDW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of biote Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Ttbio Corp. (6493.TWO) Income Statement Analysis – Financial Results
- DPCM Capital, Inc. (XPOA-UN) Income Statement Analysis – Financial Results
- PTT Exploration and Production Public Company Limited (PEXNY) Income Statement Analysis – Financial Results
- Blue Planet Investment Trust plc (BLP.L) Income Statement Analysis – Financial Results
- Plum Acquisition Corp. III (PLMJU) Income Statement Analysis – Financial Results
biote Corp. (BTMDW)
About biote Corp.
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 185.36M | 164.96M | 139.40M | 116.57M | 109.98M |
| Cost of Revenue | 57.88M | 54.58M | 48.82M | 44.93M | 43.57M |
| Gross Profit | 127.48M | 110.38M | 90.58M | 71.64M | 66.41M |
| Gross Profit Ratio | 68.78% | 66.92% | 64.98% | 61.46% | 60.39% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 165.50M | 49.05M | 33.02M | 32.03M |
| Selling & Marketing | 0.00 | 4.63M | 4.91M | 4.41M | 7.26M |
| SG&A | 98.83M | 170.13M | 53.96M | 37.43M | 39.29M |
| Other Expenses | 0.00 | 974.00K | 2.06M | 2.43M | 3.59M |
| Operating Expenses | 98.83M | 171.10M | 56.02M | 39.86M | 42.88M |
| Cost & Expenses | 156.70M | 225.68M | 104.84M | 84.79M | 86.45M |
| Interest Income | 0.00 | 5.09M | 1.67M | 2.43M | 2.08M |
| Interest Expense | 6.36M | 5.09M | 1.67M | 2.43M | 2.08M |
| Depreciation & Amortization | 2.99M | 2.44M | 1.40M | 1.14M | 832.00K |
| EBITDA | 9.23M | 9.24M | 35.98M | 32.91M | 24.29M |
| EBITDA Ratio | 4.98% | -34.83% | 24.81% | 28.24% | 22.09% |
| Operating Income | 28.66M | -60.72M | 34.56M | 31.78M | 23.53M |
| Operating Income Ratio | 15.46% | -36.81% | 24.79% | 27.26% | 21.39% |
| Total Other Income/Expenses | -28.78M | 62.43M | -1.66M | -2.43M | -2.15M |
| Income Before Tax | -123.00K | 1.71M | 32.91M | 29.35M | 21.38M |
| Income Before Tax Ratio | -0.07% | 1.04% | 23.61% | 25.18% | 19.44% |
| Income Tax Expense | 2.68M | 388.00K | 286.00K | 189.00K | 93.00K |
| Net Income | 3.32M | 1.32M | 32.62M | 29.16M | 21.29M |
| Net Income Ratio | 1.79% | 0.80% | 23.40% | 25.02% | 19.36% |
| EPS | 0.13 | 0.16 | -0.87 | 3.85 | 2.81 |
| EPS Diluted | 0.13 | 0.16 | -0.87 | 3.85 | 2.81 |
| Weighted Avg Shares Out | 25.71M | 8.06M | 7.57M | 7.57M | 7.57M |
| Weighted Avg Shares Out (Dil) | 25.71M | 8.06M | 7.57M | 7.57M | 7.57M |
Source: https://incomestatements.info
Category: Stock Reports